331 related articles for article (PubMed ID: 20943662)
1. Calcineurin signaling regulates human islet {beta}-cell survival.
Soleimanpour SA; Crutchlow MF; Ferrari AM; Raum JC; Groff DN; Rankin MM; Liu C; De León DD; Naji A; Kushner JA; Stoffers DA
J Biol Chem; 2010 Dec; 285(51):40050-9. PubMed ID: 20943662
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function.
Park S; Dong X; Fisher TL; Dunn S; Omer AK; Weir G; White MF
J Biol Chem; 2006 Jan; 281(2):1159-68. PubMed ID: 16272563
[TBL] [Abstract][Full Text] [Related]
3. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling.
Dai C; Hang Y; Shostak A; Poffenberger G; Hart N; Prasad N; Phillips N; Levy SE; Greiner DL; Shultz LD; Bottino R; Kim SK; Powers AC
J Clin Invest; 2017 Oct; 127(10):3835-3844. PubMed ID: 28920919
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
6. Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells.
Demozay D; Tsunekawa S; Briaud I; Shah R; Rhodes CJ
Diabetes; 2011 Nov; 60(11):2892-902. PubMed ID: 21940781
[TBL] [Abstract][Full Text] [Related]
7. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line.
Hong SW; Lee J; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Mol Cell Endocrinol; 2012 Oct; 362(1-2):242-52. PubMed ID: 22820130
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.
Kim MJ; Kang JH; Park YG; Ryu GR; Ko SH; Jeong IK; Koh KH; Rhie DJ; Yoon SH; Hahn SJ; Kim MS; Jo YH
J Endocrinol; 2006 Mar; 188(3):623-33. PubMed ID: 16522741
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 stimulates islet cell replication via the IGF1 receptor activation of mTORC1/S6K1.
Xie J; El Sayed NM; Qi C; Zhao X; Moore CE; Herbert TP
J Mol Endocrinol; 2014 Aug; 53(1):105-15. PubMed ID: 24994913
[TBL] [Abstract][Full Text] [Related]
10. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation.
Liu Z; Habener JF
J Biol Chem; 2008 Mar; 283(13):8723-35. PubMed ID: 18216022
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca
Zummo FP; Krishnanda SI; Georgiou M; O'Harte FP; Parthsarathy V; Cullen KS; Honkanen-Scott M; Shaw JA; Lovat PE; Arden C
Autophagy; 2022 Apr; 18(4):799-815. PubMed ID: 34338148
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus inhibits insulin release and promotes apoptosis of Min6 cells through the inhibition of the PI3K/Akt/mTOR pathway.
Tong L; Li W; Zhang Y; Zhou F; Zhao Y; Zhao L; Liu J; Song Z; Yu M; Zhou C; Yu A
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278483
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells.
Natalicchio A; De Stefano F; Orlando MR; Melchiorre M; Leonardini A; Cignarelli A; Labarbuta R; Marchetti P; Perrini S; Laviola L; Giorgino F
Endocrinology; 2010 May; 151(5):2019-29. PubMed ID: 20219981
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
17. NFAT targets signaling molecules to gene promoters in pancreatic β-cells.
Lawrence MC; Borenstein-Auerbach N; McGlynn K; Kunnathodi F; Shahbazov R; Syed I; Kanak M; Takita M; Levy MF; Naziruddin B
Mol Endocrinol; 2015 Feb; 29(2):274-88. PubMed ID: 25496032
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats.
Park S; Hong SM; Sung SR
Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation.
Song WJ; Schreiber WE; Zhong E; Liu FF; Kornfeld BD; Wondisford FE; Hussain MA
Diabetes; 2008 Sep; 57(9):2371-81. PubMed ID: 18544709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
